Lung Cancer
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global lung cancer drug development, clinical trials, regulatory approvals, and market trends. Inform your pharma strategy.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Lung Cancer hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Kelun-Biotech's ASCO 2026 Presentation: Key Insights on NSCLC
Kelun and Merck's Lung Cancer Combo Shows Promise in China
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.